155 related articles for article (PubMed ID: 35350568)
21. Cardiac peroxiredoxins undergo complex modifications during cardiac oxidant stress.
Schröder E; Brennan JP; Eaton P
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H425-33. PubMed ID: 18502910
[TBL] [Abstract][Full Text] [Related]
22. Typical 2-Cys Peroxiredoxins as a Defense Mechanism against Metal-Induced Oxidative Stress in the Solitary Ascidian
Drago L; Ferro D; Bakiu R; Ballarin L; Santovito G
Antioxidants (Basel); 2021 Dec; 11(1):. PubMed ID: 35052596
[TBL] [Abstract][Full Text] [Related]
23. The Prognosis Of Peroxiredoxin Family In Breast Cancer.
Wang G; Zhong WC; Bi YH; Tao SY; Zhu H; Zhu HX; Xu AM
Cancer Manag Res; 2019; 11():9685-9699. PubMed ID: 31814764
[TBL] [Abstract][Full Text] [Related]
24. Protective Role of Peroxiredoxins against Reactive Oxygen Species in Neonatal Rat Testicular Gonocytes.
O'Flaherty C; Boisvert A; Manku G; Culty M
Antioxidants (Basel); 2019 Dec; 9(1):. PubMed ID: 31905831
[TBL] [Abstract][Full Text] [Related]
25. Expression of peroxiredoxins and thioredoxins in the mouse spinal cord during embryonic development.
Pirson M; Knoops B
J Comp Neurol; 2015 Dec; 523(17):2599-617. PubMed ID: 25975898
[TBL] [Abstract][Full Text] [Related]
26. Dimeric peroxiredoxins are druggable targets in human Burkitt lymphoma.
Trzeciecka A; Klossowski S; Bajor M; Zagozdzon R; Gaj P; Muchowicz A; Malinowska A; Czerwoniec A; Barankiewicz J; Domagala A; Chlebowska J; Prochorec-Sobieszek M; Winiarska M; Ostaszewski R; Gwizdalska I; Golab J; Nowis D; Firczuk M
Oncotarget; 2016 Jan; 7(2):1717-31. PubMed ID: 26636537
[TBL] [Abstract][Full Text] [Related]
27. Systematic Characterization of Prognostic Values of Peroxiredoxin Family in Gastric Cancer.
Xu R; Pan J; Mei J; Zhang Q
Biomed Res Int; 2020; 2020():3948183. PubMed ID: 32382548
[TBL] [Abstract][Full Text] [Related]
28. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Zhu W; Ye Z; Chen L; Liang H; Cai Q
Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
[TBL] [Abstract][Full Text] [Related]
29. Oxidative stress and altered expression of peroxiredoxin genes family (PRDXS) and sulfiredoxin-1 (SRXN1) in human lung tissue following exposure to sulfur mustard.
Tahmasbpour Marzony E; Ghanei M; Panahi Y
Exp Lung Res; 2016 May; 42(4):217-26. PubMed ID: 27266564
[TBL] [Abstract][Full Text] [Related]
30. Ainsliadimer A induces ROS-mediated apoptosis in colorectal cancer cells via directly targeting peroxiredoxin 1 and 2.
Lv C; Huang Y; Wang Q; Wang C; Hu H; Zhang H; Lu D; Jiang H; Shen R; Zhang W; Liu S
Cell Chem Biol; 2023 Mar; 30(3):295-307.e5. PubMed ID: 36889312
[TBL] [Abstract][Full Text] [Related]
31. AKT3 is a key regulator of head and neck squamous cell carcinoma.
Takahashi H; Rokudai S; Kawabata-Iwakawa R; Sakakura K; Oyama T; Nishiyama M; Chikamatsu K
Cancer Sci; 2021 Jun; 112(6):2325-2334. PubMed ID: 33811778
[TBL] [Abstract][Full Text] [Related]
32. Aberrant overexpression of transcription factor Forkhead box D1 predicts poor prognosis and promotes cancer progression in HNSCC.
Li J; Yan T; Wu X; Ke X; Li X; Zhu Y; Yang J; Li Z
BMC Cancer; 2021 Nov; 21(1):1205. PubMed ID: 34772357
[TBL] [Abstract][Full Text] [Related]
33. Identification of Immune Subtypes for Predicting the Prognosis of Patients in Head and Neck Squamous Cell Carcinoma.
Sun J; Fang G; Zuo Z; Yu X; Xue L; Li C; Li S
Technol Cancer Res Treat; 2021; 20():15330338211045823. PubMed ID: 34657509
[TBL] [Abstract][Full Text] [Related]
34. A Study on the Correlations of the miR-31 Expression with the Pathogenesis and Prognosis of Head and Neck Squamous Cell Carcinoma.
Qiang H; Zhan X; Wang W; Cheng Z; Ma S; Jiang C
Cancer Biother Radiopharm; 2019 Apr; 34(3):189-195. PubMed ID: 30628842
[TBL] [Abstract][Full Text] [Related]
35. Peroxiredoxins - Urinary Surveillance Biomarkers in Urothelial Cancer.
Kumari N; Vasudeva P; Tanwar P; Hussain S; Kumar A; Agrawal U
J Cancer; 2022; 13(9):2751-2756. PubMed ID: 35812179
[No Abstract] [Full Text] [Related]
36. CMTM4 regulates epithelial-mesenchymal transition and PD-L1 expression in head and neck squamous cell carcinoma.
Li H; Liu YT; Chen L; Zhou JJ; Chen DR; Li SJ; Sun ZJ
Mol Carcinog; 2021 Aug; 60(8):556-566. PubMed ID: 34061408
[TBL] [Abstract][Full Text] [Related]
37. Quercetin induces the expression of peroxiredoxins 3 and 5 via the Nrf2/NRF1 transcription pathway.
Miyamoto N; Izumi H; Miyamoto R; Kondo H; Tawara A; Sasaguri Y; Kohno K
Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):1055-63. PubMed ID: 21051700
[TBL] [Abstract][Full Text] [Related]
38. High expression of CLEC10A in head and neck squamous cell carcinoma indicates favorable prognosis and high-level immune infiltration status.
Zou M; Wu H; Zhou M; Xiao F; Abudushalamu G; Yao Y; Zhao F; Gao W; Yan X; Fan X; Wu G
Cell Immunol; 2022 Feb; 372():104472. PubMed ID: 35093731
[TBL] [Abstract][Full Text] [Related]
39. Identification of PSMD7 as a prognostic factor correlated with immune infiltration in head and neck squamous cell carcinoma.
Zhang S; Yu S; Wang J; Cheng Z
Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33687056
[TBL] [Abstract][Full Text] [Related]
40. High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma.
Li B; Zhu J; Meng L
Mol Med Rep; 2019 Feb; 19(2):877-884. PubMed ID: 30535476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
